Remdesivir and hospitalization outcomes in patients with COVID -19 in the period of SARS-CoV-2 Delta circulation

QR Code

Remdesivir and hospitalization outcomes in patients with COVID -19 in the period of SARS-CoV-2 Delta circulation

Aim of the study is to analyze the effect of remdesivir on the outcome of hospitalization in patients with COVID-19 during the period of the SARS-CoV-2 Delta predominance. Material and methods. Among 11203 patients hospitalized from the pandemics start until June 2023 in the Minsk City Clinical Hosp...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Litvinchuk, D. E. Danilov, I. A. Karpov
Format:	Article
Language:	Russian
Published:	Journal Infectology 2025-06-01
Series:	Журнал инфектологии
Subjects:	covid-19 sars-cov-2 delta variant remdesivir antiviral therapy
Online Access:	https://journal.niidi.ru/jofin/article/view/1791
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The problem of SARS-CoV-2 virus resistance to direct-acting antivirals
by: E. L. Gasich, et al.
Published: (2024-12-01)

The Characteristics of the Delta Variant of SARS-CoV-2 Virus – the Dominant Agent of the Third and Forth Waves of Epidemic COVID-19 in Russia
by: T. E. Sizikova, et al.
Published: (2023-06-01)

Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir
by: Kalpana Gupta, et al.
Published: (2025-05-01)

Remdesivir Versus Sotrovimab in Coronavirus Disease 2019: A Systematic Review and Meta‐Analysis
by: Saeed Khorramnia, et al.
Published: (2025-07-01)

From Delta to Omicron—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland
by: Maria Miklasińska-Majdanik, et al.
Published: (2025-07-01)

Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
by: Darius Babusis, et al.
Published: (2025-06-01)

Influence of SARS-CoV-2 variants’ spike glycoprotein and RNA-dependent RNA polymerase (nsp12) mutations on remdesivir docking residues
by: Ali A. Dawood
Published: (2022-07-01)

The Effect of Carriage of <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19
by: I. I. TEMIRBULATOV, et al.
Published: (2022-11-01)

SARS-CoV-2 Delta variant induces severe damage in the nasal cavity from the first day post-infection in the Syrian hamster model
by: Maxime Fusade-Boyer, et al.
Published: (2025-12-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Comparative analysis of the genomic diversity of SARS-COV-<sub>2</sub> circulating in the territories of the Rostov region and the republic of Crimea in the period from March to June 2021
by: A. K. Noskov, et al.
Published: (2021-09-01)

The Omicron Variant of SARS-CoV-2 Virus: the Ability to Cause Disease in Persons with Immunity against COVID-19
by: T. E. Sizikova, et al.
Published: (2023-06-01)

Functional and Evolutionary Characterization of the NSP6 Protein in SARS-CoV-2 Omicron Variants
by: Joyhare Barbosa Souza, et al.
Published: (2025-04-01)

Molecular Docking Studies of Marine Sulfated Polysaccharides: Exploring Green Seaweed’s Role Against SARS-CoV-2 Spike Glycoprotein
by: Azalia Puspa Herida, et al.
Published: (2024-12-01)

New Evidence on the Evolution of the COVID-19 Pandemic: Literature Review
by: Leyla S. Namazova-Baranova, et al.
Published: (2021-10-01)

Confirmed Delta Variant COVID-19 Infection at A Single Centre Tertiary Hospital: A Case Series
by: Sally Aman Nasution, et al.
Published: (2022-07-01)

Antiviral Activity of Kagocel<sup>®</sup> in vitro Against Virus SARS-CoV-2
by: S. Ya. Loginova, et al.
Published: (2020-06-01)

Population Genomics of SARS-CoV-2 in the Constituent Entities of Siberian and Far Eastern Federal Districts
by: L. V. Mironova, et al.
Published: (2023-05-01)

Comparison of two polymerase chain reaction assays, DaAn Gene (DaAn Gene 2019-ncov) and Cepheid (Cepheid Xpert Xpress SARS-CoV-2) for Delta and Omicron variants of SARS-CoV-2 detection in Yaoundé, Cameroon
by: Martin Maidadi-Foudi, et al.
Published: (2025-07-01)

Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids
by: Meaghan Flagg, et al.
Published: (2023-12-01)

Inhibitory activity of tea compositions and their constituent ingredients on SARS‐COV‐2 replication in vitro
by: Е. I. Каzachinskaia, et al.
Published: (2022-07-01)

Comprehensive insights into the therapeutic effects of baicalein and baicalin against SARS-COV-2 infection
by: Cheng-Han Lin, et al.
Published: (2025-08-01)

Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
by: Lucia Inchauste, et al.
Published: (2025-07-01)

Comparative Analysis of the Diversity of SARS-CoV-2 Lines Circulating in Omsk Region in 2020–2022
by: E. A. Gradoboeva, et al.
Published: (2023-01-01)

Amacha, a Japanese sweet tea, inhibits infection by pseudoviruses expressing the SARS-CoV-2 spike protein
by: Tomokazu Ohishi, et al.
Published: (2025-09-01)

RADx Variant Task Force Program for Assessing the Impact of Variants on SARS-CoV-2 Molecular and Antigen Tests
by: Richard Creager, et al.
Published: (2021-01-01)

Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya
by: Caitlin Greenland-Bews, et al.
Published: (2025-06-01)

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
by: Abundio Balgos, et al.
Published: (2024-12-01)

Antiviral Activity of Benzydamine Hydrochloride against SARS-CoV-2 in vitro Model
by: V. V. Lebedeva, et al.
Published: (2021-07-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01)

Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein
by: Alexandra Rak, et al.
Published: (2025-05-01)

Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
by: Yu-An Kung, et al.
Published: (2025-07-01)

Clinical and laboratory markers of the new coronavirus disease SARS-CoV-2 COVID-19 in hospitalized patients
by: L.R. Shostakovych-Koretskaya , et al.
Published: (2021-12-01)

Editorial: Emerging SARS-COV-2 variants: genomic variations, transmission, pathogenesis, clinical impact and interventions, volume III
by: Deepak Y. Patil, et al.
Published: (2025-07-01)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
by: Yanping Hu, et al.
Published: (2023-12-01)

Droplet digital RT-PCR method for SARS-CoV-2 variants detection in clinical and wastewater samples
by: Feng Wang, et al.
Published: (2025-07-01)

Detection of SARS‑CoV‑2 S Gene Mutations Using PCR during Seasons of Increased Incidence of Coronavirus Infection in the Chuvash Republic
by: N. P. Prishchepa, et al.
Published: (2024-01-01)

Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection
by: Yue Shen, et al.
Published: (2025-06-01)

Structural basis for varying drug resistance of SARS-CoV-2 Mpro E166 variants
by: Morgan A. Esler, et al.
Published: (2025-07-01)